LONZA GROUP AG
LONZA GROUP AG
Action · CH0013841017 · 928619 (XSWX)
Aperçu
Résumé de la Note des Analystes
gauge-img
Conserver
Achat fort
Achat
Conserver
Vente
Vente forte
0
1
2
0
0
Pas de cours
Cours de clôture XSWX 28.10.2025: 570,20 CHF
28.10.2025 19:55
Cours actuels de LONZA GROUP AG
BourseTickerDeviseDernier échangeCoursVariation journalière
XSWX: SIX
SIX
LONN.SW
CHF
28.10.2025 16:03
570,20 CHF
-8,40 CHF
-1,45 %
Flottant et Liquidité des Actions
Flottant Libre 99,95 %
Actions en Flottant 70,03 M
Actions en Circulation 70,07 M
Fonds investis

Les fonds suivants ont investi dans LONZA GROUP AG :

Fonds
iShares SLI UCITS ETF (DE)
Vol. en millions
14.723,26
Part (%)
5,00 %
Fonds
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. en millions
1.647,10
Part (%)
3,77 %
Fonds
iShares MSCI Europe SRI UCITS ETF EUR (Acc)
Vol. en millions
80.571,18
Part (%)
2,17 %
Fonds
iShares MSCI Europe SRI UCITS ETF USD (Acc)
Vol. en millions
1.014,09
Part (%)
2,17 %
Fonds
iShares MSCI Europe SRI UCITS ETF EUR (Dist)
Vol. en millions
15.293,46
Part (%)
2,17 %
Profil de l'entreprise pour LONZA GROUP AG Action
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Obtenez des informations actualisées de finAgent sur LONZA GROUP AG

Données de l'entreprise

Nom LONZA GROUP AG
Société Lonza Group AG
Site web https://www.lonza.com
Marché d'origine XSWX SIX
WKN 928619
ISIN CH0013841017
Type de titre Action
Secteur Healthcare
Industrie Medical - Diagnostics & Research
PDG Wolfgang Wienand
Capitalisation boursière 37 Mrd.
Pays Suisse
Devise CHF
Employés 18,0 T
Adresse Muenchensteinerstrasse 38, 4002 Basel
Date d'introduction en bourse 1999-11-01

Symboles boursiers

Nom Symbole
Frankfurt LO3.F
SIX LONN.SW
XETRA LO3.DE
Autres actions
Les investisseurs qui détiennent LONZA GROUP AG ont également les actions suivantes dans leur portefeuille :
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
BONDCO 733 S.A. 17-40
BONDCO 733 S.A. 17-40 Obligation
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
FASTENAL CO
FASTENAL CO Action
FIDELITY EUROPEAN HIGH YIELD A €
FIDELITY EUROPEAN HIGH YIELD A € Fonds
GRAND PHARM. GRP.  HD-,01
GRAND PHARM. GRP. HD-,01 Action
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Action
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Action
REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC Action
XTRACKERS BLOOMBERG BARCLAYS US INVESTMENT GRADE CORPRATE ESG ETF
XTRACKERS BLOOMBERG BARCLAYS US INVESTMENT GRADE CORPRATE ESG ETF ETF
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025